Astrid Pharma Inc, an early-stage biotech firm, pioneers the BioCapZ technology platform for safe and efficient drug delivery, accommodating various drug classes from small molecules to biologics.
Technology Advantages:
BioCapZ, based on the patented virus capsid, excels over competitors entering the body without triggering the immune system. A stealth delivery system technology.
Astrid's business model involves partnerships and licensing deals to generate immediate revenues. Internal product development efforts focus on the BioCapZ platform, ensuring maximum value retention. Revenues from partnerships de-risk the company, while internal development efforts maximize technology platform value.
Company Details
- Employees
- 1
- Founded
- -
- Address
- Davis, California
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.astridpharma.com
- Keywords
- nano, drug delivery, DNA, mRNA, icosahedral scaffold.
- HQ
- Davis, California
Astrid Pharma Questions
Astrid Pharma's website is http://www.astridpharma.com
Astrid Pharma's LinkedIn profile is https://www.linkedin.com/company/astrid-pharma
Astrid Pharma has
1 employees.
View email and phone details for 1
employees at Astrid Pharma.
Astrid Pharma's industry is
Biotechnology Research
Astrid Pharma's top competitors are
Receptorpharma Inc,
Mimabs Sas,
Amaran Biotech,
Igi,
Cycuria Therapeutics,
Eze System, Inc.,
Out Of Business,
Pearl Biosystem,
Aastrid Life Sciences Pvt Ltd,
Astrocyte Pharmaceuticals.
Astrid Pharma's categories are Biotechnology Research
Astrid Pharma's founding year is 2017
